Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio
July 12, 2021 08:33 ET
|
Inotiv, Inc.
WEST LAFAYETTE, Ind., July 12, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and...